Midfacial Advancement Line-A Comparative Evaluation of a New Measurement Method in Orthognathic Surgery.


Journal

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
ISSN: 1531-5053
Titre abrégé: J Oral Maxillofac Surg
Pays: United States
ID NLM: 8206428

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 07 11 2018
revised: 08 10 2019
accepted: 10 10 2019
pubmed: 30 11 2019
medline: 18 9 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

In planning intraoral quadrangular Le Fort II osteotomy (IQLFIIO), simulation of hard and soft tissue changes will be important at the infraorbital, Le Fort I, and incisor level. The aim of our study was to evaluate a new method for visualization and quantification. Three different methods of quantification were compared: the point-to-point (PTP) measurement, which has been viewed as the reference standard; part comparison analysis (PCA); and a new method, the midfacial advancement line (MFAL) measurement. We performed a measurement comparison study using the Bland-Altman method to measure agreement and enrolled patients with midfacial deficiency and Class III malocclusion who had undergone IQLFIIO. The primary predictor variable was the method of measurement. The primary outcome variable was the amount of midfacial advancement. We also investigated the time required, visualization quality, and interobserver agreement. The sample included 12 subjects with a mean age of 21.6 years; 7 patients were male. The PTP and MFAL showed no significant observer dependence. The advancement measured with PTP and MFAL showed no significant differences. However, the advancement measured using MFAL and PCA showed a significant difference. The highest rating of visualization was found for MFAL. The time requirements were similar for all 3 methods. Our results have shown that the MFAL is a suitable method for visualization and quantification of soft and hard tissue changes at all 3 face levels in 1 image. It could be a valuable tool for virtual planning of midfacial advancement surgery.

Identifiants

pubmed: 31778641
pii: S0278-2391(19)31241-8
doi: 10.1016/j.joms.2019.10.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

286.e1-286.e9

Informations de copyright

Copyright © 2019 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Katrin Willinger (K)

Radiographer and Researcher, Department of Craniofacial, Maxillofacial, and Oral Surgery, University Clinic of Craniofacial and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria. Electronic address: n09501464@students.meduniwien.ac.at.

Julia Cede (J)

Resident, Department of Craniofacial, Maxillofacial, and Oral Surgery, University Clinic of Craniofacial and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.

Godoberto Guevara-Rojas (G)

Researcher, University of Applied Sciences, FH Campus Wien, Wien, Austria.

Klaus Sinko (K)

Orthodontist, Department of Craniofacial, Maxillofacial, and Oral Surgery, University Clinic of Craniofacial and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.

Michael Figl (M)

Professor and Physicist, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.

Kurl Schicho (K)

Professor and Senior Researcher, Department of Craniofacial, Maxillofacial, and Oral Surgery, University Clinic of Craniofacial and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.

Stefan Nemec (S)

Professor and Radiologist, University Clinic of Radiology, Medical University of Vienna, Vienna, Austria.

Clemens Klug (C)

Professor and Senior Physician, Department of Craniofacial, Maxillofacial, and Oral Surgery, University Clinic of Craniofacial and Maxillofacial Surgery, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH